Andra AP fonden Sells 38,200 Shares of Agilent Technologies, Inc. $A

Key Points

• Andra AP fonden cut its Agilent Technologies stake by 37.6%, selling 38,200 shares and retaining 63,300 shares valued at approximately $8.4 million.
• Analyst sentiment remains positive, with a consensus “Moderate Buy” rating and an average price target of $170.33; several institutional investors also increased their holdings.
• Agilent recently exceeded quarterly earnings and revenue expectations, while shares traded near their 52-week high. The company also declared a quarterly dividend of $0.255 per share, representing a 0.6% yield.

Andra AP fonden reduced its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 37.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 63,300 shares of the medical research company's stock after selling 38,200 shares during the quarter. Andra AP fonden's holdings in Agilent Technologies were worth $8,408,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of A. State Street Corp lifted its position in shares of Agilent Technologies by 0.7% in the 2nd quarter. State Street Corp now owns 12,854,230 shares of the medical research company's stock worth $1,710,658,000 after purchasing an additional 89,598 shares during the period. The Manufacturers Life Insurance Company increased its holdings in Agilent Technologies by 9.7% during the second quarter. The Manufacturers Life Insurance Company now owns 163,805 shares of the medical research company's stock valued at $21,758,000 after buying an additional 14,435 shares during the period. Sequoia Financial Advisors LLC increased its holdings in Agilent Technologies by 14.3% during the second quarter. Sequoia Financial Advisors LLC now owns 48,278 shares of the medical research company's stock valued at $6,413,000 after buying an additional 6,041 shares during the period. Tidal Investments LLC raised its stake in Agilent Technologies by 7.1% in the second quarter. Tidal Investments LLC now owns 275,185 shares of the medical research company's stock worth $36,553,000 after buying an additional 18,128 shares in the last quarter. Finally, National Pension Service lifted its stake in shares of Agilent Technologies by 7.0% during the 2nd quarter. National Pension Service now owns 469,501 shares of the medical research company's stock worth $62,364,000 after purchasing an additional 30,730 shares during the last quarter.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Wolfe Research reaffirmed a "hold" rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Piper Sandler assumed coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They issued a "neutral" rating and a $150.00 price target on the stock. Royal Bank Of Canada lifted their price objective on shares of Agilent Technologies from $155.00 to $185.00 and gave the stock an "outperform" rating in a research report on Thursday, August 27th. Morgan Stanley boosted their price objective on shares of Agilent Technologies from $160.00 to $175.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 12th. Finally, Weiss Ratings raised shares of Agilent Technologies from a "hold (c)" rating to a "hold (c+)" rating in a research report on Friday, September 11th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $170.33.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the firm's stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $151.38, for a total value of $95,974.92. Following the sale, the director directly owned 4,924 shares of the company's stock, valued at approximately $745,395.12. This trade represents a 11.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Agilent Technologies Price Performance

Shares of NYSE A opened at $167.50 on Wednesday. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $167.59. The business's 50 day moving average price is $146.99 and its 200 day moving average price is $130.37. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. The firm has a market cap of $47.22 billion, a P/E ratio of 32.97, a P/E/G ratio of 2.47 and a beta of 1.24.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.13. The firm had revenue of $1.88 billion during the quarter, compared to analysts' expectations of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm's revenue was up 8.1% compared to the same quarter last year. During the same quarter last year, the company posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 6.2 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th will be paid a $0.255 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Tuesday, October 6th. Agilent Technologies's payout ratio is currently 20.08%.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical instruments, laboratory software, consumables and services used by organizations in the life sciences, diagnostics, pharmaceutical, chemical, environmental and food industries. Its solutions help customers analyze the composition and quality of substances, develop and manufacture products, and conduct research and testing.

The company's offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic analysis equipment, automated electrophoresis systems, laboratory informatics software, columns and other consumables.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.